July 9, 2020

Quality measure OP-35—the first chemo-specific measure in the Centers for Medicare & Medicaid Services Hospital Outpatient Quality Reporting Program—went into effect for payment determination this year. To be fully prepared, Mercy Cancer Care—ACCC Innovator Award winner—looked at 90,000 of their qualifying chemotherapy visits that met the criteria for measure OP-35 and identified the clinical variables associated with patients’ increased risk of hospital admissions or ED visits. Based on that data, Mercy developed a predictive algorithm that identifies and manages chemotherapy patients who are at high risk.